Somatic deletions were also observed in 67% prostate tumor samples [92] and deletions encompassing B55α and B55β genes PPP2R2A and PPP2R2B were found in primary plasma cell leukemia [93] and in multiple myeloma patients [94], respectively. This evidence concerns the gene PPP2R2A and plasma cell myeloma.